Stocks rallied today, lead mainly by the large cap names. Trading volume eased, giving some indication the bounce from recent lows may be tiring. Leading names and small caps lagged the market. It’s becoming tough to find quality entry points, as many stocks are rolling over. Curiously, biotechs lost ground today. If this trend continues, which I doubt it will, […]
Submitted by Daniel Drew via Dark-Bid.com,Biotech has a special place in the heart of the gambler investor. In the modern market where the average investor doesn’t stand a chance, some of them indulge their hope and turn to lottery tickets. If only they can get the next Gilead or the next Amgen, they will become the next wildly successful “maverick” […]
Several major biotech companies like Biogen (BIIB – Analyst Report), AbbVie (ABBV – Analyst Report), Celgene and Gilead reported second quarter results over the last five trading days. Biogen has been grabbing headlines for the wrong reasons – although the company’s earnings were better-than-expected, revenues missed expectations.With the company saying that it is cutting its outlook based on revised expectations […]
The best-performing Canadian stocks amid the commodities rout have one thing in common: the mighty U.S. dollar. Earnings estimates compiled by Bloomberg suggest their run will continue.How short sellers are building up a new front in their war on Canadian stocksThe TSX has been weighed down the past year by commodities. But now it faces a new threat: foreign investors […]
(Drivebycuriosity) – “The end of capitalism has begun”, claims the British paper “The Guardian” (theguardian). The text looks like a wet socialist dream. Paul Mason, a Marxist and author of this article, declares that information technology (Internet, software, cloud computing and more) will destroy capitalism and replace it by “postcapitalism”.I disagree. Capitalism is just changing its face, as it has […]
Tweet
Tweet
Some Long-Term Charts At Key Inflection PointsBe aware of these surroundings, friends!by Chris Kimble.It could pay to be “aware of these surroundings!”(1) – Nasdaq Composite Index (COMP) is back at 2000 highs, with little wiggle room at the top of this rising wedge pattern(2) – Google (GOOG) (GOOGL) shot up after earnings two weeks ago hitting a resistance line based […]
Fed Officials May Offer More Clarity on Rates (WSJ)
Stocks rebound, shrugging off volatile and weak China (Reuters)
Three-Day Selloff Knocks 11% From China Shares (WSJ)
China shares fall again as Beijing scrambles to calm markets (Reuters)
VAT hikes to make Greek destination less popular (Kathimerini)
Varoufakis – Something is rotten with the eurozone’s hideous restrictions on sovereignty (FT)
EU denies Varoufakis ‘tax control’ claims (FT)
Allergan […]
Dr. Ed’s BlogThis is an excellent article about when the next recession will start. Dr. Ed Yardeni is worth heeding, and you could bookmark his blog to stay in touch with Ed for more information. He believes the next recession might start around March of 2019. This means that we should ride the stock market until we are near the […]
Below is just a snapshot of the Full Report
(login required) Not a member yet? Join Now.
This report is provided free each week by McAlinden Research Partners to members of Hedge Connection.
Big Pharma Refills its Blockbuster Pipeline While the Generics Consolidate
MRP
MCALINDEN RESEARCH PARTNERS | DIBS
This Week’s Issue Cluster: Pharma
Generic drugmakers get on the megamerger bandwagon
New blockbuster branded drugs are coming down the pike, including Alzheimer’s, malaria, and cholesterol.
US […]
Related TEVATeva Still A ‘Must-Own’ Stock, Worth $86Benzinga’s Top UpgradesWeekly 52-Week Highs Highlight: GIS, AAP, BCR, TEVA(GuruFocus)Shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) surged to new 52-week highs of $69.42 on Monday after the company announced its acquisition of Allergan PLC (NYSE: AGN)’s Generics segment for a total consideration of $40.5 billion.Shares of Allergan also spiked to new […]
